These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 30417798

  • 1. Hybridized Quinoline Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and Molecular Docking.
    Selim MR, Zahran MA, Belal A, Abusaif MS, Shedid SA, Mehany ABM, Elhagali GAM, Ammar YA.
    Anticancer Agents Med Chem; 2019; 19(4):439-452. PubMed ID: 30417798
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors.
    Shobeiri N, Rashedi M, Mosaffa F, Zarghi A, Ghandadi M, Ghasemi A, Ghodsi R.
    Eur J Med Chem; 2016 May 23; 114():14-23. PubMed ID: 26974371
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors.
    Mirzaei S, Eisvand F, Hadizadeh F, Mosaffa F, Ghasemi A, Ghodsi R.
    Bioorg Chem; 2020 May 23; 98():103711. PubMed ID: 32179282
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of 2-phenylquinoline-4-carboxamide derivatives as a new class of tubulin polymerization inhibitors.
    Zhu L, Luo K, Li K, Jin Y, Lin J.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5939-5951. PubMed ID: 28988750
    [Abstract] [Full Text] [Related]

  • 5. Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives.
    Othman DIA, Selim KB, El-Sayed MA, Tantawy AS, Amen Y, Shimizu K, Okauchi T, Kitamura M.
    Bioorg Med Chem; 2019 Oct 01; 27(19):115026. PubMed ID: 31416740
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
    Wang G, Peng Z, Zhang J, Qiu J, Xie Z, Gong Z.
    Bioorg Chem; 2018 Aug 01; 78():332-340. PubMed ID: 29627654
    [Abstract] [Full Text] [Related]

  • 7. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF, Abdelmoniem AM, Elwahy AHM, Abdelhamid IA.
    Curr Cancer Drug Targets; 2018 Aug 01; 18(4):372-381. PubMed ID: 28669339
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
    Zhou Y, Yan W, Cao D, Shao M, Li D, Wang F, Yang Z, Chen Y, He L, Wang T, Shen M, Chen L.
    Eur J Med Chem; 2017 Sep 29; 138():1114-1125. PubMed ID: 28763646
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS, Hawwas MM, Taher ES, Alhakamy NA, Alfaleh MA, Elagawany M, Elgendy B, Zayed GM, Mohamed MFA, Abdel-Samii ZK, Elshaier YAMM.
    Bioorg Chem; 2020 Dec 29; 105():104352. PubMed ID: 33080494
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents.
    Srivastava V, Lee H.
    Bioorg Med Chem; 2015 Dec 15; 23(24):7629-40. PubMed ID: 26602827
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
    Moussa SA, A Osman EE, Eid NM, Abou-Seri SM, El Moghazy SM.
    Future Med Chem; 2018 Aug 01; 10(16):1907-1924. PubMed ID: 29966433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
    Vyas VK, Variya B, Ghate MD.
    Eur J Med Chem; 2014 Jul 23; 82():385-93. PubMed ID: 24929289
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L.
    Bioorg Med Chem; 2014 Apr 01; 22(7):2060-79. PubMed ID: 24629450
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
    Alblewi FF, Okasha RM, Hritani ZM, Mohamed HM, El-Nassag MAA, Halawa AH, Mora A, Fouda AM, Assiri MA, Al-Dies AM, Afifi TH, El-Agrody AM.
    Bioorg Chem; 2019 Jun 01; 87():560-571. PubMed ID: 30928878
    [Abstract] [Full Text] [Related]

  • 17. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE, Hassan RA.
    Bioorg Chem; 2018 Oct 01; 80():531-544. PubMed ID: 30014921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
    Batran RZ, Kassem AF, Abbas EMH, Elseginy SA, Mounier MM.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3474-3490. PubMed ID: 29793751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.